0001096906-24-000515.txt : 20240319 0001096906-24-000515.hdr.sgml : 20240319 20240319192423 ACCESSION NUMBER: 0001096906-24-000515 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Rourke Peter CENTRAL INDEX KEY: 0001890749 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54296 FILM NUMBER: 24765736 MAIL ADDRESS: STREET 1: C/O NORTHVIEW ACQUISITION CORP. STREET 2: 207 WEST 25TH STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001514946 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 274092986 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (212) 751-0001 MAIL ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AXIM INTERNATIONAL INC. DATE OF NAME CHANGE: 20110309 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-15 0 0001514946 AXIM BIOTECHNOLOGIES, INC. AXIM 0001890749 O'Rourke Peter 6191 CORNERSTONE COURT, E. SUITE 114 SAN DIEGO CA 92121 1 0 0 0 0 Convertible Note 0.0100 2024-03-15 4 A 0 35000.0000 35000.0000 A 2024-03-15 2034-03-01 Common Stock 3500000.0000 4500000.0000 D Reporting Person acquired a convertible note, face value $35,000. The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share. /s/ Peter O'Rourke 2024-03-18